巴克莱-美股-生命科学与诊断行业-Jack工具包——第4卷第4期：从PRA健康的战略伙伴关系来分析增长-2018.1.18-23页

EquityResearch18January2018BarclaysCapitalInc.and/oroneofitsaffiliatesdoesandseekstodobusinesswithcompaniescoveredinitsresearchreports.Asaresult,investorsshouldbeawarethatthefirmmayhaveaconflictofinterestthatcouldaffecttheobjectivityofthisreport.Investorsshouldconsiderthisreportasonlyasinglefactorinmakingtheirinvestmentdecision.PLEASESEEANALYSTCERTIFICATION(S)ANDIMPORTANTDISCLOSURESBEGINNINGONPAGE17.U.S.LifeScienceTools&DiagnosticsJack’sToolKit–Vol.4,Issue4:AnalyzingGrowthfromPRAHealth’sStrategicPartnershipsJack’sToolKit–WhatisthepotentialgrowthcontributionfromPRAHealth’srecentstrategicpartnerships?TriviaQuestion:HowmanynewdrugswereapprovedbytheFDAin2017(within5)?RecentNotes&Reports:1)Tools&Dx:LabDirectorSurveySays:SeeingInterestinPAMA-DrivenOutsourcing,Near-TermDxTrendsAppearPositive2)LifeScienceTools&Dx:We